Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies

Insulinomas are considered rare indolent neuroendocrine neoplasms in human medicine, however when metastases occur no curative treatment is available thus, novel therapies are needed. Recently advances have been made in unraveling the pathophysiology of malignant insulinoma still major challenges hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ylenia Capodanno, Barbara Altieri, Richard Elders, Annamaria Colao, Antongiulio Faggiano, Joerg Schrader
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/e68e51b74641445d9c1c86121b7dbe5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e68e51b74641445d9c1c86121b7dbe5c
record_format dspace
spelling oai:doaj.org-article:e68e51b74641445d9c1c86121b7dbe5c2021-11-18T04:46:27ZCanine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies1936-523310.1016/j.tranon.2021.101269https://doaj.org/article/e68e51b74641445d9c1c86121b7dbe5c2022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1936523321002606https://doaj.org/toc/1936-5233Insulinomas are considered rare indolent neuroendocrine neoplasms in human medicine, however when metastases occur no curative treatment is available thus, novel therapies are needed. Recently advances have been made in unraveling the pathophysiology of malignant insulinoma still major challenges hinder the development of a functional model to study them. Canine malignant insulinoma have similar recurrence and a poor prognosis as human malignant insulinoma. Additionally, both human and canine patients share extensively the same environment, tend to develop insulinoma seemingly spontaneously with an etiological role for hormones, at a similar incidence and stage of lifespan, with metastasis commonly to liver and regional lymph nodes, which are unresponsive to current therapies. However, the occurrence of metastases in dogs is as high as 95% compared with only 5–16% in human studies. From a comparative oncology perspective, the shared features with human insulinoma but higher incidence of metastasis in canine insulinoma suggests the latter as a model for human malignant insulinomas. With the common purpose of increasing survival rates of human and veterinary patients, in this review we are going to compare and analyze clinical, pathological and molecular aspects of canine and human insulinomas to evaluate the suitability of the canine model for future translational clinical studies.Ylenia CapodannoBarbara AltieriRichard EldersAnnamaria ColaoAntongiulio FaggianoJoerg SchraderElsevierarticleComparative oncologyMalignant insulinomaTranslational medicineCanine modelPancreatic neuroendocrine tumorNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTranslational Oncology, Vol 15, Iss 1, Pp 101269- (2022)
institution DOAJ
collection DOAJ
language EN
topic Comparative oncology
Malignant insulinoma
Translational medicine
Canine model
Pancreatic neuroendocrine tumor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Comparative oncology
Malignant insulinoma
Translational medicine
Canine model
Pancreatic neuroendocrine tumor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ylenia Capodanno
Barbara Altieri
Richard Elders
Annamaria Colao
Antongiulio Faggiano
Joerg Schrader
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
description Insulinomas are considered rare indolent neuroendocrine neoplasms in human medicine, however when metastases occur no curative treatment is available thus, novel therapies are needed. Recently advances have been made in unraveling the pathophysiology of malignant insulinoma still major challenges hinder the development of a functional model to study them. Canine malignant insulinoma have similar recurrence and a poor prognosis as human malignant insulinoma. Additionally, both human and canine patients share extensively the same environment, tend to develop insulinoma seemingly spontaneously with an etiological role for hormones, at a similar incidence and stage of lifespan, with metastasis commonly to liver and regional lymph nodes, which are unresponsive to current therapies. However, the occurrence of metastases in dogs is as high as 95% compared with only 5–16% in human studies. From a comparative oncology perspective, the shared features with human insulinoma but higher incidence of metastasis in canine insulinoma suggests the latter as a model for human malignant insulinomas. With the common purpose of increasing survival rates of human and veterinary patients, in this review we are going to compare and analyze clinical, pathological and molecular aspects of canine and human insulinomas to evaluate the suitability of the canine model for future translational clinical studies.
format article
author Ylenia Capodanno
Barbara Altieri
Richard Elders
Annamaria Colao
Antongiulio Faggiano
Joerg Schrader
author_facet Ylenia Capodanno
Barbara Altieri
Richard Elders
Annamaria Colao
Antongiulio Faggiano
Joerg Schrader
author_sort Ylenia Capodanno
title Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
title_short Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
title_full Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
title_fullStr Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
title_full_unstemmed Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
title_sort canine insulinoma as a model for human malignant insulinoma research: novel perspectives for translational clinical studies
publisher Elsevier
publishDate 2022
url https://doaj.org/article/e68e51b74641445d9c1c86121b7dbe5c
work_keys_str_mv AT yleniacapodanno canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
AT barbaraaltieri canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
AT richardelders canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
AT annamariacolao canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
AT antongiuliofaggiano canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
AT joergschrader canineinsulinomaasamodelforhumanmalignantinsulinomaresearchnovelperspectivesfortranslationalclinicalstudies
_version_ 1718425072254844928